Core Scientific, Inc.: 5%+ holders

As of November 7, 2026, 7 holders' latest Schedule 13D or 13G filings report owning 5% or more of Core Scientific, Inc. The largest reported stake is BlackRock, Inc.'s, at 7.8%. 42 filings are on record since July 16, 2025 (Schedule 13G/A, July 16, 2025).

Situational Awareness LP also filed stake reports on 2 other companies ↓

Sell to companies like Core Scientific, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Your website Find my buyers

Opens in a new tab. No signup.

Key facts

• Filed 2026-11-06 · Holder: Jane Street Group, LLC · Percent: 2.9% · SCHEDULE 13G/A
• Filing 2026-10-28 · Reporting person: MFN Partners, LP · Sole voting: 0 · Shared voting: 24,488,600 · Sole dispositive: 0 · Shared dispositive: 24,488,600 · SCHEDULE 13G, 2026-10-28
• Filing 2026-08-14 · Reporting person: Jericho Capital Asset Management L.P. · Sole voting: 0 · Shared voting: 22,882,942 · Sole dispositive: 0 · Shared dispositive: 22,882,942 · SCHEDULE 13G, 2026-08-14
• Filing 2026-08-14 · Reporting person: Valiant Capital Management, L.P. · Sole voting: 0 · Shared voting: 16,956,009 · Sole dispositive: 0 · Shared dispositive: 16,956,009 · SCHEDULE 13G/A, 2026-08-14
• Filed 2026-08-14 · Holder: Pentwater Capital Management LP · Percent: 0.4% · SCHEDULE 13G/A

Core Scientific, Inc. has 42 Schedule 13D or 13G filings on record since 2025-07-16. 7 holders' latest filing reports 5% or more of common stock, par value $0.00001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Stated intent

Intent stated in Item 4 Two Seas Capital LP

The Reporting Persons intend to solicit proxies against the Issuer's proposal to adopt the Merger Agreement at the Special Meeting and also intend to file a proxy statement in connection with the Special Meeting, if and when it is scheduled.From Item 4 of the SCHEDULE 13D filed 2025-08-08

Holders

Swipe the table sideways to see every column.

Holding shares or following this stake? See who's behind Core Scientific, Inc. and the warning signs.

See Core Scientific, Inc.'s free Snapshot Watch Core Scientific, Inc.: email me the next time it files something

Free to see. No signup.

Keep reading

More on Core Scientific, Inc. and the records around it.

Core Scientific, Inc. elsewhere on the record

• Leadership changes Jul 2026
• Who owns it

Companies that share a holder

• Situational Awareness LP also filed stake reports on 2 other companies: SharonAI Holdings Inc. (Sep 2026)
• Jericho Capital Asset Management L.P. also filed stake reports on 4 other companies: Lionsgate Studios Corp. (May 2026), Madison Square Garden Entertainment Corp. (Feb 2026)
• MFN Partners, LP also filed stake reports on 4 other companies: RXO, Inc. (Oct 2026), XPO, Inc. (Aug 2026), CNX RESOURCES CORPORATION (May 2026)

Want the whole picture on Core Scientific, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Core Scientific, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Core Scientific, Inc. covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   45 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

Voting and dispositive power, as filed

Swipe the table sideways to see every column.

The latest filing identifies Core Scientific, Inc. by CUSIP 21874A106 and gives its principal executive office as 838 WALKER ROAD, DOVER, DE 19904 (SCHEDULE 13G/A, 2026-11-06).

What the percentages are based on

The information required by this paragraph is set forth in the cover pages to this Schedule 13G and is incorporated herein by reference. Percentage ownership is based on 321,340,441 shares of Common Stock outstanding as of July 23, 2026, as reported in the Issuer's Report on Form 10-Q for the period ended June 30, 2026 filed with the Securities and Exchange Commission on July 28, 2026.MFN Partners, LP, SCHEDULE 13G, 2026-10-28

Timeline

Swipe the table sideways to see every column.

Questions about who owns Core Scientific, Inc.

Who owns Core Scientific, Inc.?

On this page, 7 holders' latest ownership filings report 5% or more of Core Scientific, Inc.: BlackRock, Inc. (7.8%, Schedule 13G/A, filed 2025-07-16), MFN Partners, LP (7.6%, Schedule 13G, filed 2026-10-28), Jericho Capital Asset Management L.P. (7.2%, Schedule 13G, filed 2026-08-14), Kenneth Griffin (6.5%, Schedule 13G, filed 2026-08-05) and Vanguard Portfolio Management (5.97%, Schedule 13G, filed 2026-04-29); 2 more are listed above.

Who are the largest shareholders of Core Scientific, Inc.?

By the share each holder's latest filing reports, the largest holders of Core Scientific, Inc. on this page are BlackRock, Inc. (7.8%), MFN Partners, LP (7.6%) and Jericho Capital Asset Management L.P. (7.2%).

When did BlackRock, Inc. buy into Core Scientific, Inc.?

The filings give report dates, not purchase dates. The earliest filing from BlackRock, Inc. on this page is the Schedule 13G/A, filed 2025-07-16, reporting 7.8%. That earliest filing is itself an amendment, which updates an earlier report.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 42 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Also on the record for Core Scientific, Inc.

Swipe the table sideways to see every column.

Tools for this story

Each opens in a new tab, filled in for Core Scientific, Inc.. With no account yet, you sign up free and land on the result.

• Get an alert when Core Scientific, Inc. is mentioned again
• Find former Core Scientific, Inc. employees to interview
• Verify a claim or statistic

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All recent stakesThat week's stakes